- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| 23.10. | Foxtons Group - Q3 Lettings resilience offset by weaker Sales | 242 | Foxton Group's Q3 Lettings revenue supported an increase of c 3% but declining confidence in the London sales market due to uncertainty related to the Autumn Budget had an impact on Sales volumes and... ► Artikel lesen | ||
| 23.10. | Boku - Outlining the growth path | 285 | At its recent capital markets event, Boku outlined how it intends to meet its medium-term growth targets. The combination of ongoing growth from existing merchants as they add new local payment connections... ► Artikel lesen | ||
| 23.10. | LTR Pharma - Sizable upside potential for intranasal delivery | 289 | LTR Pharma is a clinical- and commercial-stage pharmaceutical company pioneering intranasal drug delivery with lead product SPONTAN, a first-in-class nasal spray for erectile dysfunction (ED). LTR has... ► Artikel lesen | ||
| 21.10. | The Diverse Income Trust - Anticipating a UK small-cap super cycle | 275 | The Diverse Income Trust's (DIVI's) managers, Gervais Williams and Martin Turner at Premier Miton Investors, are currently remarkably upbeat. Usually, when market leadership becomes too concentrated... ► Artikel lesen | ||
| 21.10. | KEFI Gold and Copper - The finish line comes into sight | 463 | Yesterday evening KEFI announced the successful conclusion of US$240m in senior project debt capital for its Tulu Kapi project in Ethiopia (accounting for 70% of the total). Focus will now shift to... ► Artikel lesen | ||
| 21.10. | Aamal Company - Diversified portfolio underpins 9M25 results | 227 | Aamal Company reported a solid 9M25 performance, with net profit attributable to shareholders up 8.2% year-on-year to QAR327.3m, supported by resilient margins across its diversified portfolio. EPS... ► Artikel lesen | ||
| 21.10. | Thessaloniki Port Authority - Preparing for Pier 6 | 266 | Thessaloniki Port Authority's H125 growth was solid, with revenues up 10.2% y-o-y, driven by strength in the container business. The H125 EBITDA margin was 45.3%, compared to 43.4% in H124. Management... ► Artikel lesen | ||
| 20.10. | OSE Immunotherapeutics - Refocusing for the next phase | 309 | OSE Immunotherapeutics' H125 results, the first since the board restructuring, reflected normalised operations typical of a clinical-stage biotech, following H124's exceptional licensing income. The... ► Artikel lesen | ||
| 20.10. | Oryzon Genomics - Making headway towards Phase III in BPD | 309 | Oryzon Genomics has announced that it has received FDA feedback on its plans for the Phase III programme in borderline personality disorder (BPD) for its lead central nervous system (CNS) drug candidate... ► Artikel lesen | ||
| 16.10. | OPAP - Bringing the team together | 716 | The proposed business combination of OPAP with its majority (51.8%) shareholder, Allwyn, via an all-share transaction provides OPAP with significantly greater scale and enhances its growth outlook as... ► Artikel lesen | ||
| 16.10. | Thrive Renewables - Results reflect UK power price normalisation | 262 | Thrive Renewables' H125 results reflect the expected transition back to normalised electricity prices, with turnover down 35% y-o-y to £9.4m (H124: £14.6m) and gross profit falling 51% to £4.3m (H124:... ► Artikel lesen | ||
| 15.10. | Theon International - Intention to acquire 9.8% stake in Exosens | 588 | Theon has agreed to acquire 9.8% of the issued shares in Exosens from existing shareholders. This is a strategic investment reflecting the strong commercial relationship between the two companies, with... ► Artikel lesen | ||
| 15.10. | discoverIE Group - Organic revenue and order growth resumes | 303 | After a long period of destocking by customers, discoverIE has reported a return to organic revenue growth, with Q226 organic revenue up 1% y-o-y and H126 up 0.5% y-o-y after previously reporting flat... ► Artikel lesen | ||
| 14.10. | Sparks - discoverIE sees return to organic growth | 280 | After a long period of destocking by customers, discoverIE has reported a return to organic revenue growth, with Q226 organic revenue up 1% y-o-y and H126 up 0.5% y-o-y (after previously reporting flat... ► Artikel lesen | ||
| 13.10. | Georgia Capital - Accelerating capital deployment | 306 | Georgia Capital (GCAP) posted strong H125 results, with NAV per share up 31% in Georgian lari and 24% in pounds sterling in total return terms, accelerating its long-term growth (five-year NAV TR in... ► Artikel lesen | ||
| 13.10. | Dialight - Back to the future | 282 | Dialight is a global leader in sustainable LED lighting for industrial applications, specifically in demanding and hazardous environments. The company's primary manufacturing facility is in Mexico and... ► Artikel lesen | ||
| 13.10. | 1Spatial - 1Streetworks prospects strengthen | 315 | 1Spatial's H1 reflected slow procurement cycles, but was supported by the company's shift to a more recurring revenue model. Strategic wins with Caltrans and UK Power Networks, along with a strong pipeline... ► Artikel lesen | ||
| 13.10. | Fevara - Targeting profitable growth | 334 | Fevara is the new name of Carr's Group, reflecting the refocusing of the business as a global leader in sustainable livestock supplements. Such supplements aim to improve digestion to enhance growth... ► Artikel lesen | ||
| 10.10. | S&U - H1 results provide positive momentum | 396 | S&U has issued interim results confirming the recovery of the business and momentum supporting full-year profit expectations. Group PBT of £15.6m was 22% higher than the prior year, driven by lower... ► Artikel lesen | ||
| 08.10. | Herantis Pharma - HER-096 clears Phase Ib, eyes Phase II | 359 | Herantis Pharma reported positive top-line results from the second part of its Phase Ib trial, evaluating lead candidate HER-096 in Parkinson's disease (PD) patients, meeting both the primary and secondary... ► Artikel lesen | ||
| 08.10. | Datatec - Excellent progress made in H126 | 383 | Datatec has seen continuing strong financial performance in H126, with growing profitability in Westcon and Logicalis International and a considerable improvement in performance for Logicalis Latin... ► Artikel lesen | ||
| 07.10. | Orell Fussli - Capital markets event in November | 210 | Orell Füssli is a diversified Swiss company operating in security printing, industrial systems, publishing, book retailing and digital identity solutions. With over 500 years of heritage, it has evolved... ► Artikel lesen | ||
| 07.10. | Percheron Therapeutics - Positive Phase I readout strengthens outlook | 404 | Percheron Therapeutics has reported final results from the Phase I dose escalation study of HMBD-002, its monoclonal antibody targeting VISTA, a novel immune checkpoint protein. The data confirmed the... ► Artikel lesen | ||
| 07.10. | Recce Pharmaceuticals - Phase III Indonesian DFI trial underway | 323 | Recce has reached a key milestone with the start of patient dosing in its Phase III Indonesian-focused study of the topical gel formulation (R327G) of its lead anti-infective therapeutic drug candidate... ► Artikel lesen | ||
| 06.10. | Lamda Development - Valuation upside potential is emerging | 408 | LAMDA Development delivered a strong H125 operational and financial performance across all segments of the business. The operational malls and marinas reached new high levels of EBITDA and the Ellinikon... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .